Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes

PURPOSE: To report the visual acuity (VA) and foveal thickness (FT) changes after intravitreal bevacizumab for diabetic macular edema (DME) in previously vitrectomized eyes

Segmentation and removal of fibrovascular membranes with high-speed 23 G transconjunctival sutureless vitrectomy, in severe proliferative diabetic retinopathy

Erkan Celik,1 Ozkan Sever,2 Fatih Horozoglu,2 Ates Yanyali3 1Sakarya University Medical Education and Research Hospital, Sakarya, 2Namik Kemal University, School of Medicine, Tekirdag, 3Haydarpasa Numune Medical Education and Research Hospital, Istanbul, Turkey Aim: To evaluate the effectiveness and safety of high-speed (5,000 cuts per minute) 23 G transconjunctival sutureless vitrectomy (TSV) in severe diabetic fibrovascular proliferation (DFVP). Patients and methods: In this retrospective consecutive case series, patients who underwent 23 G TSV for severe DFVP between October 2011 and March 2014 at our institution were evaluated. 23 G TSV was performed with a high-speed (5,000 cuts per minute) cutter without a chandelier light. Results: The mean follow-up period was 8 months (range: 4–23 months). Of the 27 eyes of 27 patients, 14 eyes (52%) underwent concomitant phacoemulsification with posterior chamber intraocular lens implantation, nine eyes (33%) were pseudophakic, and four eyes were phakic (15%). DFVP was removed with ease in all, and visual acuity was improved in 18 (67%) eyes. Iatrogenic retinal tear was observed in four eyes (15%) and treated successfully during surgery. Suture placement to a single sclerotomy was performed in eight eyes (30%). Postoperative intraocular hemorrhage was observed in five eyes (18%). Cataract formation was observed in two of the four phakic eyes. Three (11%) patients had postoperative intraocular pressure rise. Postoperative hypotony (≤6 mmHg) and endophthalmitis were not observed in any eye. Conclusion: The segmentation and removal of fibrovascular membranes with high-speed 23 G TSV seems to be a safe and easy method in severe diabetic eye disease. Keywords: diabetic fibrovascular proliferation, transconjunctival sutureless vitrectomy, high spee

Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema

Purpose: To report the long-term visual results and anatomical outcome as assessed by optical coherence tomography (OCT) after pars plana vitrectomy (PPV) with removal of the internal limiting membrane (ILM) in diabetic macular edema (DME)

Pars Plana Vitrectomy and Intravitreal Phacoemulsification for Dislocated Crystalline Lens during Cataract Surgery

Purpose: To evaluate the effectiveness, timing and safety of intravitreal phacoemulsification with pars plana vitrectomy (PPV) in patients with posteriorly dislocated crystalline lens during cataract surgery

Primary 25-gauge transconjunctival sutureless vitrectomy in pseudophakic retinal detachment

Aims: There are few reports on 25-gauge transconjunctival sutureless vitrectomy (TSV) in cases of pseudophakic retinal detachment. We conducted this study to report the anatomic and functional outcomes of 25-gauge TSV in the treatment of primary pseudophakic retinal detachment (RD). Design: Prospective, interventional case series. Materials and Methods: Fifteen eyes of 15 patients with RD after cataract surgery with phacoemulsification were evaluated. Primary pseudophakic RDs with macular detachment and proliferative vitreoretinopathy Stage B or less were included in the study. Pars plana vitrectomy with the 25-gauge TSV system, perfluorocarbon liquid injection followed by air exchange, endolaser photocoagulation and sulfur hexafluoride gas (20%) injection were applied to all eyes. Results: Mean follow-up time was 9.2 months (range, six to 12 months). Retinal reattachment with a single operation was achieved in 93% of eyes and with additional surgery, the retina was reattached in 100% of eyes. Preoperative visual acuity was less than 20/200 in all eyes (range, hand motions to 20/400). Postoperative visual acuity was 20/40 or better in eight eyes (53%) and between 20/50 and 20/200 in seven eyes (47%). No severe hypotony was encountered and no sutures were required to close the scleral and conjunctival openings. Postoperative complications were macular pucker in one eye (7%) and cystoid macular edema in another eye (7%). Conclusions: Primary 25-gauge TSV system appears to be an effective and safe procedure in the treatment of uncomplicated pseudophakic RD

Transconjonctival Sutureless Pars Plana Vitrectomy

Purpose: To evaluate the effectiveness, feasibility and safety of the transconjunctival sutureless vitrectomy (TSV) system for a variety of vitreoretinal procedures

Heavy Silicone Oil Tamponade for Complicated Retinal Detachment

Purpose: To report the early postoperative outcomes of perfluorohexyloctane/ silicone oil solution (Densiron-68) as an ocular endotamponade in the management of complicated retinal detachments involving the inferior quadrants

Arteriovenous Adventitial Sheathotomy for Macular Branch Retinal Vein Occlusion

Purpose: To report the clinical course of a patient with macular branch retinal vein occlusion (MBRVO) who underwent pars plana vitrectomy (PPV) with internal limiting membrane (ILM) removal and arteriovenous (AV) adventitial sheathotomy

Primary 23-gauge vitreoretinal surgery for rhegmatogenous retinal detachment

AIM: To report the effectiveness and safety of primary 23-Gauge (G) vitreoretinal surgery for rhegmatogenous retinal detachment (RRD)